New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
09:25 EDTSNTI, SNTI, SRNE, SRNE, SPEX, SPEX, CDXC, CDXC, CBMX, CBMX, SSET, SSET, OPK, OPK, CGIX, CGIXRedChip Companies to hold a virtual conference
RedChip Emerging Growth Showcase is being held on January 22-23 with webcasted presentations to begin on January 23 at 9:30 am. Webcast Link
Check below for free stories on OPK;CGIX;SNTI;SRNE;SPEX;CDXC;CBMX;SSET the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
08:32 EDTCGIXCancer Genetics IVD for cervical cancer receives CE Mark
Cancer Genetics announced that their proprietary DNA-probe based test for cervical cancer, or FHACT, has received the CE Marking. The CE marking indicates the test's compliance with European Union product safety legislation and allows FHACT to be sold freely within the European Economic Area, or EEA, which includes the 28 member states of the EU as well as the European Free Trade Association. Cancer Genetics' proprietary FHACT test, which can identify irreversible genomic changes associated with progression to cancer, adds predictive value to this screening protocol. In addition to identifying those women most at risk for cervical disease, it can help reduce unnecessary, invasive testing and over-treatment in women who do not show the genomic abnormalities associated with disease progression.
06:03 EDTSPEXSpherix issued three new patents by USPTO
Spherix announced that the United States Patent & Trademark Office, or USPTO, issued three patents to the company in the month of August that are part of a standard essential family of patents.
August 29, 2014
16:50 EDTSPEXSpherix files $30M mixed securities shelf
Subscribe for More Information
08:16 EDTSNTISenesco Technologies closes enrollment in Phase 1b/2a SNS01-T study
Subscribe for More Information
August 27, 2014
08:02 EDTCGIXCancer Genetics' proprietary tests added to NIH's genetic testing registry
Subscribe for More Information
August 26, 2014
08:47 EDTSRNESorrento Therapeutics receives funding to advance with WISP1 research
Subscribe for More Information
August 25, 2014
08:01 EDTCGIXCancer Genetics announces collaboration to identify, evaluate DLBCL markers
Subscribe for More Information
06:21 EDTSPEXSpherix announces first trial of Nortel patents scheduled against Verizon for Q1
Spherix (SPEX) announced that on August 19, the Honorable Gerald Bruce Lee, United States District Judge for the Eastern District of Virginia, in Case No. 1:14-cv-00721 -GBL-TCB, issued a scheduling order in the company's patent litigation against Verizon Services; Verizon South; Verizon Virginia; Verizon Communications; Verizon Federal; Verizon Business Network Services; MCI Communications Services, collectively Verizon (VZ). The judge ordered both parties to appear for a pretrial conference on September 10, and ordered discovery to be complete by December 12. The order also states the trial of this case will be within four to eight weeks after the December 18 final pretrial conference.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use